Ms. Seiler is a graduate of Mount Carmel College of Nursing and received her Master of Science in nursing from Otterbein College. Ms. Seiler worked as a staff RN for six years at Mid Ohio Oncology/Hematology (now The Mark H. Zangmeister Center) before obtaining her certification as a nurse practitioner. Her clinical experience includes work at The Arthur G. James Hospital, Mount Carmel Urgent Care, Mount Carmel OB/GYN Clinic, Southwest Pediatrics and Children’s Hospital Surgery Team. She is a member of the Oncology Nursing Society, Ohio Academy of Advanced Practice Nurses and the American Academy of Nurse Practitioners.
Archive for the ‘Ohio Cancer Center’ Category
Jennifer Seiler
Thursday, October 29th, 2009
CHEMOTHERAPY / INFUSION
Tuesday, August 25th, 2009
Infusion is the administration of fluids, including chemotherapy and blood products, into the bloodstream of patients who require them.
More than half of all people diagnosed with cancer receive chemotherapy, treatments that use drugs to kill affected cells. For millions of people who have conditions that respond well to chemotherapy, this approach helps them to enjoy full, productive lives. Many side effects once associated with chemotherapy are now easily prevented or controlled, allowing many people to work, travel and participate in normal activities while receiving treatment.
Our infusion area features 90 comfortable infusion chairs situated in a naturally lit, open space. To pass the time, the center offers a variety of pleasant distractions – including Wi-Fi, reading materials and plenty of windows – all contributing to the warm, caring environment.
Clinical Trials
Tuesday, August 25th, 2009
Access to the most advanced treatments depends heavily on strong clinical trial programs. The Zangmeister Center is an active participant in a broad range of research studies in cooperation with pharmaceutical companies, The Gynecologic Oncology Group and The National Cancer Institute’s Cooperative Groups (including Southwest Oncology Group and the Eastern Cooperative Group), through the Columbus Community Clinical Oncology Program. Clinical trials give patients broader access to new treatment options and are essential to our mission of providing the most advanced care available to the patients we serve. In addition to providing promising alternatives to our patients today, these studies can dramatically improve the prognoses for generations of future oncology patients.
GYNECOLOGIC ONCOLOGY
Tuesday, August 25th, 2009
The gynecologic oncologists working at the Zangmeister Center specialize in the diagnosis and treatment of cancers of the female reproductive organs. Following referral from another treating physician, our practice may provide consultation and management of complex benign gynecologic conditions as well.
We are experienced in the use of surgery, radiation therapy and/or chemotherapy as required. In certain cases, our physicians may choose laser treatments, laparoscopy or the DaVinci Robotic system in selecting the most appropriate treatment modality for each patient.
Cheryl Carr, M.S.N., C.N.P., C.N.S., A.O.C.N.
Monday, August 24th, 2009
Ms. Carr received her Bachelor of Science in Nursing from Ohio University and her Master of Science in nursing/adult nurse practitioner degree from Otterbein College. Prior to joining The Mark H. Zangmeister Center, she worked as an oncology nurse practitioner in Zanesville, Ohio. She serves as a facilitator of a Zanesville-area support group for the Central Ohio Leukemia/Lymphoma Society and is an “I Can Cope” program facilitator for the American Cancer Society. Ms. Carr is founding president of the SEO Oncology Nursing Society and a member of the National Oncology Nursing Society, from which she received the Roberta Scofield Memorial Certification Award. She is also a fellow of the Leadership Development Institute and a member of Outreach Ohio American Cancer Society (former president), Ohio Association of Advanced Practice Nurses, American College of Nurse Practitioners and the American Society of Clinical Oncology. Ms. Carr has been honored for her volunteer work by the Ohio House of Representatives.
Louis Rivello, Jr., M.D.
Monday, August 24th, 2009
 A graduate of the University of Akron, Dr. Rivello received his medical degree from Northeastern Ohio Universities College of Medicine and completed his residency in radiation oncology at The Ohio State University Hospitals, where he served as chief resident in the Division of Radiation Oncology. Board certified in radiation oncology by the American Board of Radiology, he is a member of the Columbus Medical Association, Ohio State Medical Association, the American Society for Therapeutic Radiology & Oncology and the American College of Radiation Oncology. Dr. Rivello serves on the Network Cancer Committee, Radiation Safety Committee and Physician Advisory Board for Hospice at Mount Carmel Health.
|
Taral Patel, M.D.
Monday, August 24th, 2009
Dr. Patel is a diplomate of the American Board of Internal Medicine in Medical Oncology. He received his M.B.B.S. from Baroda Medical College at Maharaja Sayairao University in Gujarat, India, where he completed his internship and residency in Pathology. Formerly a research associate at the University of Illinois at Chicago, he completed his residency in Internal Medicine at Chicago’s Cook County Hospital and his fellowship in Hematology/Oncology at the University of Cincinnati. The author of many peer-reviewed publications, Dr. Patel is a member of the Community Oncology Alliance, Columbus Medical Association, The Ohio State Medical Association, Ohio Hematology Oncology Society and the American Society of Clinical Oncology.
Mark E. Thompson, M.D.
Monday, August 24th, 2009
Dr. Thompson is a Diplomate of the American Board of Internal Medicine, the American Board of Medical Examiners and the American Board of Internal Medicine-Medical Oncology. Prior to receiving his medical degree, Dr. Thompson worked as a microbiologist at Scioto Memorial Hospital in Portsmouth, Ohio. He received his M.D. from Wright State University School of Medicine in Dayton, Ohio. Dr. Thompson served his residency in Internal Medicine at Mount Carmel Medical Center in Columbus, where he was Co-Chief Administrative Medical Resident. He completed his fellowship in Hematology/Oncology at the University of Kentucky Medical Center in Lexington. A board member of the Community Oncology Alliance and its current secretary, Dr. Thompson is also a member of the American College of Physician Executives, American College of Physicians, American Society of Clinical Oncology, Columbus Community Clinical Oncology Program, Franklin County Academy of Medicine, National Adjuvant Surgical Breast & Bowel Project, Columbus Medical Association, Ohio State Medical Association, Ohio Hematology Oncology Society and Southwest Oncology Group. He has been a member of multiple advisory committees regarding cancer care and information technologies for Mount Carmel Health Systems and served on its Board of Trustees from 1995-2001. Dr. Thompson is the past Medical Director and Managing Partner of The Mark H. Zangmeister Center, having served in this role for over twenty years.
Mark L. Segal, M.D., F.A.C.P.
Monday, August 24th, 2009
Dr. Segal received his medical degree from The Ohio State University and completed his internship and residency at Wayne State University in Detroit, where he was Assistant Professor of Medicine. He completed his fellowship in the Division of Hematology/Oncology at The Ohio State University. Board certified in Medical Oncology and Hematology by the American Board of Internal Medicine, Dr. Segal is on the teaching staff at Mount Carmel Medical Center in Columbus and is Clinical Assistant Professor of Medicine at The Ohio State University. He formerly served as medical director at Hospice of Columbus and as chairman of the Department of Medicine at Mount Carmel Medical Center. Dr. Segal is a board member of the American Cancer Society in Columbus. A fellow of the American College of Physicians, he is a member of American Society of Clinical Oncology, American Society of Hematology, Community Oncology Alliance, Columbus Community Clinical Oncology Program, Southwest Oncology Group, National Surgical Adjuvant Bowel/Breast Protocol, Academy of Hospice Physicians, National Hemophilia Foundation, Columbus Medical Association, Ohio State Medical Association and Ohio Hematology Oncology Society.
Timothy D. Moore, M.D.
Monday, August 24th, 2009
A graduate of the University of Pittsburgh School of Medicine, Dr. Moore served his internship at the University of Cincinnati School of Medicine, and his residency at Mercy Hospital in Pittsburgh, finishing as Chief Resident. He completed his fellowship at The Ohio State University School of Medicine, Division of Hematology/Oncology. Dr. Moore served as Senior Investigator, Clinical Investigations Branch, then as Senior Investigator, Developmental Chemotherapy Section, Investigational Drug Branch, both in the Cancer Therapy Evaluation Program at the National Cancer Institute. From 1992 to 1994, Dr. Moore was attending physician at NCI-Navy Medical Oncology Services at Bethesda National Naval Hospital and Project Officer for the Investigational Chemotherapy Combination Contract at the Southern Research Institute at the University of Maryland. Dr. Moore serves as Medical Director for Palliative Care at Grant Medical Center in Columbus, and is board certified by the American Board of Internal Medicine in General Internal Medicine, Hematology, Medical Oncology, and Hospice and Palliative Care Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology, American Society of Hematology, Community Oncology Alliance, Columbus Medical Association, The Ohio State Medical Association and the Ohio Hematology Oncology Society.
« Back to Medical Oncology/Hematology Physicians
